# NOVAVAX INC (NVAX) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from NOVAVAX INC's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/NVAX/mda/fy2025/): filed 2026-02-26; accession 0001000694-26-000007 (https://www.sec.gov/Archives/edgar/data/1000694/000100069426000007/nvax-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/NVAX/mda/fy2024/): filed 2025-02-27; accession 0001000694-25-000004 (https://www.sec.gov/Archives/edgar/data/1000694/000100069425000004/nvax-20241231.htm)
- [FY 2023 MD&A](/company/NVAX/mda/fy2023/): filed 2024-02-28; accession 0001000694-24-000007 (https://www.sec.gov/Archives/edgar/data/1000694/000100069424000007/nvax-20231231.htm)
- [FY 2022 MD&A](/company/NVAX/mda/fy2022/): filed 2023-02-28; accession 0001000694-23-000005 (https://www.sec.gov/Archives/edgar/data/1000694/000100069423000005/nvax-20221231.htm)
- [FY 2021 MD&A](/company/NVAX/mda/fy2021/): filed 2022-03-01; accession 0001000694-22-000004 (https://www.sec.gov/Archives/edgar/data/1000694/000100069422000004/nvax-20211231.htm)

Back to /company/NVAX/